Integrating GPRC5D-Targeting Bispecifics for Relapsed/Refractory MM

News
Video

Beth Faiman, PhD, MSN, explores how a GPRC5D-targeting bispecific antibody can benefit patients with relapsed/refractory multiple myeloma.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
Image of a man wearing scrubs and a name tag in front of a watercolor Oncology Nursing News background
Image of a man wearing a black t-shirt smiling in front of a blue background
Headshot of a woman with black hair wearing a pearl necklace and a white blouse
Related Content
Image of blood cancer cells

Subcutaneous Daratumumab Reduces Smoldering Myeloma Progression

Russ Conroy
September 30th 2025
Article
The Vitals

Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

Lindsay Fischer
September 30th 2025
Podcast
Photo of a woman with blonde hair wearing a white and black blazer

Managing CRS in Hematologic Cancers: A Nursing Perspective

Gina Mauro
September 30th 2025
Article
Beth Faiman Discusses Recent Changes in Multiple Myeloma Treatment Landscape

Beth Faiman Discusses Recent Changes in Multiple Myeloma Treatment Landscape

Lindsay Fischer
September 30th 2025
Podcast
Image of multiple myeloma cells

Personalizing Neurotoxicity Monitoring After CAR T-Cell Therapy

Bridget Hoyt
September 30th 2025
Article
Graphic of clinicians inspecting a large diagram of a bone with an oversized magnifying glass

What Are the Barriers to CAR T-Cell Therapy Access in Multiple Myeloma?

Bridget Hoyt
September 30th 2025
Article